Résumé
Faced with a scarcity of treatments for neglected diseases, experts and governmental organizations have lately proposed to build strong pull incentives around transferable vouchers. Inventors would be granted, and allowed to sell these vouchers to pharmas desiring to extend their exclusive IP rights. However, we know little about how such “Transferable Exclusivity Extensions” fare relative to prizes, who is likely to acquire them and at what cost for society, or how the burden is shared among nations. We shed light on these questions, both from a theoretical perspective and from an empirical analysis of European data.
Mots-clés
Vouchers; pull mechanisms; burden sharing; administered drug prices; prizes;
Codes JEL
- I18: Government Policy • Regulation • Public Health
- L5: Regulation and Industrial Policy
- O3: Technological Change • Research and Development • Intellectual Property Rights
Référence
Pierre Dubois, Paul-Henri Moisson et Jean Tirole, « The Economics of Transferable Patent Extensions », TSE Working Paper, n° 22-1377, novembre 2022, révision décembre 2022.
Voir aussi
Publié dans
TSE Working Paper, n° 22-1377, novembre 2022, révision décembre 2022